Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: Rationale and design of a magnetic resonance imaging study

American Journal of Cardiology

Volumn 93, Issue 8 SUPPL. 1, 2004, Pages 44-46

  Klein, Liviu ^a   Gattis, Wendy A ^b   Borrello, Francesco ^a   Wu, Edwin ^a   O'Connor, Christopher M ^b   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID MIXTURE; PLACEBO;

ARTICLE; DIABETES MELLITUS; HEART FAILURE; HEART VENTRICLE REMODELING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUPPLEMENTATION; SYSTOLE;

EID: 1942420723     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.010     Document Type: Article

References (16)

1. American Heart Association. Heart and Stroke Statistics. 2003 update. 2002;American Heart Association, Dallas, Texas.
2. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure the Framingham study. Am J Cardiol. 34:1974;29-34.
3. Garcia M.J., McNamara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetics in the Framingham population sixteen year follow-up study. Diabetes. 23:1974;105-111.
4. Solang L., Malmerg K., Ryden L. Diabetes mellitus and congestive heart failure further knowledge needed. Eur Heart J. 20:1999;789-795.
5. Zoghbi W.A. Evaluation of myocardial viability with contrast echocardiography. Am J Cardiol. 90:2002;65J-71J.
6. Chaudhry F.A., Tauke J.T., Alessandrini R.S., Vardi G., Parker M.A., Bonow R.O. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 34:1999;730-738.
7. Seghatol F.F., Shah D.J., Di Luzio S., Bello D., Johnson M.R., Cotts W.C., O'Donohue J.A., Bonow R.O., Gheorghiade M., Rigolin V.H. Relation between contractile reserve and improvement in left ventricular function with beta blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 93:2004;854-859.
8. Stanly W.C., Chandler M.P. Energy metabolism in the normal and failing heart potential for therapeutic interventions. Heart Fail Rev. 7:2002;115-130.
9. From A.H. Should manipulation of myocardial substrate utilization patterns be a component of the congestive heart failure treatment paradigm? J Card Fail. 4:1998;127-129.
10. Stanley W.C., Hoppel C.L. Mitochondrial dysfunction in heart failure potential for therapeutic interventions? Cardiovasc Res. 45:2000;805-806.
11. Li S.H., McNeill J.H. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats. Mol Cell Biochem. 217:2001;121-129.
12. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet. 343:1994;155-158.
13. Bello D., Shah D.J., Farah G.M., Di Luzio S., Parker M., Johnson M.R., Cotts W.S., Klocke F.J., Bonow R.O., Judd R.M., Georghiade M., Kim R.J. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 108:2003;1945-1953.
14. Green C.P., Porter C.B., Bresnahan D.R., Spertus J.A. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire a new health status measure for heart failure. J Am Coll Cardiol. 35:2000;1245-1255.
15. Kim R.J., Wu E., Rafael A., Chen E.-L., Parker M.A., Simonetti O., Klocke F.J., Bonow R.O., Judd R.M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453.
16. Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA. 290:2003;1884-1890.